New Findings from University of Utah in Small Lymphocytic Lymphoma Provides New Insights (Nccn Guidelines Update: Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma).
In: Clinical Trials Week, 2024-04-08, S. 864-864
serialPeriodical
Zugriff:
A report from the University of Utah discusses new findings on small lymphocytic lymphoma (SLL), a type of cancer characterized by the accumulation of abnormal lymphocytes. The report emphasizes the importance of a comprehensive evaluation of multiple factors to determine the most appropriate treatment approach for each patient. Factors such as IGHV status, del(17p)/TP53 mutation status, age, comorbidities, prior therapy, and resistance mutations should be considered in the selection of therapy. The report also highlights the importance of enrolling patients in clinical trials when available, as there is currently no clear evidence of a functional cure for SLL. [Extracted from the article]
Copyright of Clinical Trials Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
New Findings from University of Utah in Small Lymphocytic Lymphoma Provides New Insights (Nccn Guidelines Update: Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma).
|
---|---|
Zeitschrift: | Clinical Trials Week, 2024-04-08, S. 864-864 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1543-6772 (print) |
Schlagwort: |
|
Sonstiges: |
|